These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30924183)

  • 1. Optimal design for high-throughput screening via false discovery rate control.
    Feng T; Basu P; Sun W; Ku HT; Mack WJ
    Stat Med; 2019 Jul; 38(15):2816-2827. PubMed ID: 30924183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False positives in the early stages of drug discovery.
    Sink R; Gobec S; Pečar S; Zega A
    Curr Med Chem; 2010; 17(34):4231-55. PubMed ID: 20939815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-stage analysis for selecting fixed numbers of features in omics association studies.
    Kawabata T; Emoto R; Nishino J; Takahashi K; Matsui S
    Stat Med; 2019 Jul; 38(16):2956-2971. PubMed ID: 30931544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis testing in high-throughput screening for drug discovery.
    Prummer M
    J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Automatic Quality Control Pipeline for High-Throughput Screening Hit Identification.
    Zhai Y; Chen K; Zhong Y; Zhou B; Ainscow E; Wu YT; Zhou Y
    J Biomol Screen; 2016 Sep; 21(8):832-41. PubMed ID: 27313114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized multi-stage designs controlling the false discovery or the family-wise error rate.
    Zehetmayer S; Bauer P; Posch M
    Stat Med; 2008 Sep; 27(21):4145-60. PubMed ID: 18444249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing Bayesian thinking to high-throughput screening for false-negative rate estimation.
    Wei X; Gao L; Zhang X; Qian H; Rowan K; Mark D; Peng Z; Huang KS
    J Biomol Screen; 2013 Oct; 18(9):1121-31. PubMed ID: 23720569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput Assays.
    Zhang JH; Kang ZB; Ardayfio O; Ho PI; Smith T; Wallace I; Bowes S; Hill WA; Auld DS
    J Biomol Screen; 2014 Jun; 19(5):651-60. PubMed ID: 24246376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating the empirical null hypothesis into the Benjamini-Hochberg procedure.
    Ghosh D
    Stat Appl Genet Mol Biol; 2012 Jul; 11(4):. PubMed ID: 22850065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two effective methods for correcting experimental high-throughput screening data.
    Dragiev P; Nadon R; Makarenkov V
    Bioinformatics; 2012 Jul; 28(13):1775-82. PubMed ID: 22563067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
    Wu Z; Liu D; Sui Y
    J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic detection of significant areas for functional data with directional error control.
    Xu P; Lee Y; Shi JQ; Eyre J
    Stat Med; 2019 Feb; 38(3):376-397. PubMed ID: 30225994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic error detection in experimental high-throughput screening.
    Dragiev P; Nadon R; Makarenkov V
    BMC Bioinformatics; 2011 Jan; 12():25. PubMed ID: 21247425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.
    White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS
    Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data.
    Makarenkov V; Kevorkov D; Zentilli P; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2006 Jun; 22(11):1408-9. PubMed ID: 16595559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.